埃巴單抗
| 單克隆抗體 | |
|---|---|
| 種類 | 完整抗體 |
| 目標 | 內毒素 |
| 臨床資料 | |
| 給藥途徑 | 靜脈注射 |
| ATC碼 |
|
| 識別資訊 | |
| CAS號 | 141410-98-2  |
| ChemSpider | |
| UNII | |
埃巴單抗（INN：Edobacomab），開發代號為E5，是一種小鼠單克隆抗體，被研究作為革蘭氏陰性細菌感染引起的敗血症的可能治療方法。
延伸閱讀
[編輯]- Greenman RL, Schein RM, Martin MA, Wenzel RP, MacIntyre NR, Emmanuel G, et al. A controlled clinical trial of E5 murine monoclonal IgM antibody to endotoxin in the treatment of gram-negative sepsis. The XOMA Sepsis Study Group. JAMA. August 1991, 266 (8): 1097–102. PMID 1865542. doi:10.1001/jama.266.8.1097.
- Bone RC, Balk RA, Fein AM, Perl TM, Wenzel RP, Reines HD, et al. A second large controlled clinical study of E5, a monoclonal antibody to endotoxin: results of a prospective, multicenter, randomized, controlled trial. The E5 Sepsis Study Group. Critical Care Medicine. June 1995, 23 (6): 994–1006. PMID 7774238. doi:10.1097/00003246-199506000-00003.
- Angus DC, Birmingham MC, Balk RA, Scannon PJ, Collins D, Kruse JA, et al. E5 murine monoclonal antiendotoxin antibody in gram-negative sepsis: a randomized controlled trial. E5 Study Investigators. JAMA. April 2000, 283 (13): 1723–30. PMID 10755499. doi:10.1001/jama.283.13.1723
.
